About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in New York | 22,668 Studies Near You | Clareo Health

Clinical Trials LocationsNew York

Clinical Trials in New York

Discover 22,668 clinical trials near New York, New York. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 20681-20700 of 22,668 trials

COMPLETEDPhase 2< 1 mile

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631

This is a Phase 2 randomized, double-blind, placebo-controlled, multicenter study of NP001 in subjects with ALS.

Amyotrophic Lateral Sclerosis

Neuraltus Pharmaceuticals, Inc.136 participantsStarted Feb 2011

Scottsdale, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +14 more locations

COMPLETEDNA< 1 mile

Documenting a Learning Curve and Test-retest Reliability of a Virtual Reality Training Simulator in Laparoscopic Surgery

NCT00435630

The purpose of this study is to determine the learning curve for each of seven tasks in a virtual reality laparoscopic simulator by medical students.

Columbia University29 participantsStarted Jul 2004

New York, New York, United States

Find Trials by Condition in New York

Breast Cancerin New York Lung Cancerin New York Prostate Cancerin New York Colorectal Cancerin New York Melanomain New York Leukemiain New York Lymphomain New York Pancreatic Cancerin New York Ovarian Cancerin New York Brain Cancerin New York Diabetes

Data from ClinicalTrials.govTerms

COMPLETEDPhase 3< 1 mile

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

NCT00671879

The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.

Lower Back Pain

Meda Pharmaceuticals830 participantsStarted Apr 2008

Birmingham, Alabama, United States • Gulf Shores, Alabama, United States • Hueytown, Alabama, United States +70 more locations

TERMINATEDPhase 2< 1 mile

A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

NCT01288079

The purpose of this study is to assess the safety and effect of TC-5214 as a single therapy in patients with major depressive disorder who exhibit inadequate response to antidepressants.

Major Depressive Disorder

AstraZeneca145 participantsStarted Feb 2011

Beverly Hills, California, United States • Chino, California, United States • Garden Grove, California, United States +60 more locations

TERMINATEDPhase 2< 1 mile

Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin

NCT00840450

This study is designed to determine whether the combination treatment of Paclitaxel and Gleevec on recurrent ovarian cancer patients or other cancers of mullerian origin will generate better clinical response than Paclitaxel alone.

NYU Langone Health14 participantsStarted Apr 2007

New York, New York, United States

TERMINATEDPhase 25.2 miles

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

NCT00734435

The purpose of this study is to determine if zonisamide SR will prevent weight gain in schizophrenic subjects who take olanzapine (Zyprexa)

SchizophreniaSchizoaffective DisorderSchizophreniform Disorder

Orexigen Therapeutics, Inc26 participantsStarted Sep 2008

National City, California, United States • Orange, California, United States • San Diego, California, United States +6 more locations

COMPLETEDPhase 38.9 miles

Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV Transmission

NCT00099359

Giving anti-HIV medications to babies born of HIV positive mothers right after birth can lower the babies' risk of contracting HIV. This study will assess the safety and efficacy of two different combinations of anti-HIV medications compared to a one drug standard regimen in preventing mother to baby transmission. The one drug standard treatment and two combinations to be studied are: 1) zidovudine, 2) zidovudine/nevirapine and 3) zidovudine/lamivudine/nelfinavir.

Disease Transmission, VerticalVertical Human Immunodeficiency Virus TransmissionHIV Infections

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1,735 participantsStarted Feb 2004

Long Beach, California, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +14 more locations

COMPLETEDPhase 311 miles

Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

NCT00955799

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

Subjective Tinnitus

Merz Pharmaceuticals GmbH455 participantsStarted Sep 2009

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +73 more locations

COMPLETEDPhase 312 miles

FS VH S/D 500 S-apr in Vascular Surgery

NCT00892957

The purpose of this study was to compare safety and efficacy of FS VH S/D 500 s-apr (FS) versus manual compression in prosthetic expanded polytetrafluoroethylene (ePTFE) graft placement.

Hemostasis in Participants Receiving Peripheral Vascular Expanded Polytetrafluoroethylene (ePTFE) Graft Prostheses

Baxter Healthcare Corporation176 participantsStarted Jul 2009

Birmingham, Alabama, United States • Tucson, Arizona, United States • Fresno, California, United States +19 more locations

COMPLETEDPhase 213 miles

Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity

NCT00709371

The purpose of this study is determine if the combination of zonisamide SR and bupropion SR are is more effective than either drug given alone or placebo in the treatment of obesity.

Orexigen Therapeutics, Inc729 participantsStarted Jul 2008

Fairhope, Alabama, United States • La Jolla, California, United States • Denver, Colorado, United States +17 more locations

COMPLETEDNA13 miles

Endobronchial Ultrasound Transbronchial Needle Aspiration Using Needle Suction Versus No Suction

NCT01734980

Cytological diagnostic accuracy between endobronchial ultrasonography endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) samples using suction versus samples when no suction is applied.

Mediastinal LymphadenopathyLung Malignancies

Northwell Health30 participantsStarted Feb 2011

Staten Island, New York, United States

COMPLETEDPhase 416 miles

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

NCT01050582

The purpose of this study is to evaluate the effects of risperidone compared with other atypical antipsychotic drugs on the physical maturity, growth and development of children, and the risk of prolactin-related adverse events (side effects) associated to these drugs.

SchizophreniaBipolar DisorderAutistic Disorder+1 more

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.244 participantsStarted Oct 2009

San Francisco, California, United States • Aurora, Colorado, United States • Altamonte Springs, Florida, United States +25 more locations

COMPLETEDPhase 319 miles

Ramelteon in Adults With Chronic Insomnia

NCT00671567

The purpose of this study is to determine the safety and efficacy of Ramelteon, once daily (QD), in adult subjects with chronic insomnia.

Chronic Insomnia

Takeda848 participantsStarted Dec 2002

Birmingham, Alabama, United States • Mobile, Alabama, United States • Mesa, Arizona, United States +67 more locations

COMPLETED29 miles

Fibromyalgia Health Outcome Study on Cost of Treatments

NCT00725101

The Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments (REFLECTIONS) Study is a 12-month, prospective observational study that will be utilized in approximately 58 care settings in the United States (US) and Puerto Rico. It is designed to examine treatment patterns and health outcomes of adult participants diagnosed by their physician with fibromyalgia (FM) and who are starting any "new pharmacologic agent" for FM. The primary benefit of this study is enhanced understanding of the disease state of FM and the role that pharmacologic treatment plays, which may help to optimize management of FM. This study will address current gaps in a rapidly growing body of literature on FM.

Eli Lilly and Company1,700 participantsStarted Jun 2008

Hot Springs, Arkansas, United States • Santa Barbara, California, United States • Danbury, Connecticut, United States +55 more locations

COMPLETEDPhase 234 miles

Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.

NCT00293657

To determine whether a single dose of intravenous lornoxicam is superior to intravenous placebo for the acute treatment of moderate or severe headache associated with a single migraine attack in patients with a history of migraine. Two-thirds of patients in this study will receive a single dose of intravenous lornoxicam (8mg or 16 mg) and one-third of patients will receive a single dose of an intravenous placebo.

Headache (Migraine)

POZEN150 participantsStarted Dec 2005

Birmingham, Alabama, United States • Mobile, Alabama, United States • Little Rock, Arkansas, United States +20 more locations

COMPLETED77 miles

Xpress Digital Mammography System Images for Computer Aided Detection Development

NCT01061138

The primary objective of this study is to acquire digital mammography images produced by the Xpress Digital Mammography System in order to develop Computer Aided Detection software and systems.

Konica Minolta Medical Imaging, USA597 participantsStarted Feb 2010

Waterbury, Connecticut, United States • Miami, Florida, United States • Iowa City, Iowa, United States +2 more locations

COMPLETEDPhase 2121 miles

Open-Label Study To Evaluate the Safety and Efficacy of the Renal Assist Device In Patients With Acute Renal Failure

NCT00511407

Although conventional hemodialysis removes waste products and corrects fluid imbalance, it does not replace critical absorptive, metabolic, endocrine, and immunologic functions performed by healthy renal tubule cells. This trial involving patients with acute renal failure evaluates the efficacy and safety of an extracorporeal renal assist device (RAD) containing human renal tubule cells connected to a conventional hemodialysis circuit. It is hypothesized that short-term (72-h) use of this cell therapeutic device will improve survival of ARF patients compared to patients receiving only conventional continuous renal replacement therapy.

Acute Renal Failure

RenaMed Biologics58 participantsStarted Mar 2004

Birmingham, Alabama, United States • Augusta, Georgia, United States • Chicago, Illinois, United States +10 more locations

TERMINATEDPhase 2121 miles

Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure

NCT00280072

* The purpose of this study is to evaluate the safety and efficacy of the RAD to determine whether the RAD is effective in reducing mortality in patients with Acute Renal Failure due to Acute Tubule Necrosis and to evaluate the safety of the RAD * If the RAD works normally when used for as long as 72 hours * If the RAD will provide added benefits to normal CVVH therapy for patients with Acute Renal Failure

Kidney Failure, Acute

RenaMed BiologicsStarted Jan 2006

Birmingham, Alabama, United States • Denver, Colorado, United States • Washington D.C., District of Columbia, United States +13 more locations

COMPLETEDPhase 2327 miles

Safety and Tolerability of QVA149 (Indacaterol/Glycopyrrolate) Compared to Placebo and to Indacaterol in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00558285

An investigational inhalation product (QVA149) for the treatment of patients with Chronic Obstructive Pulmonary Disease (COPD) is being developed. This 14 day study will investigate the effect on heart rate and cardiovascular effects to ensure the product is safe.

Chronic Obstructive Pulmonary Disease (COPD)

Novartis257 participantsStarted Nov 2007

Adelaide, Australia • Clayton, Australia • Daw Park, Australia +37 more locations

COMPLETEDPhase 21643 miles

Evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in Type 2 Diabetes Mellitus (TD2M) Patients

NCT01020123

The primary aim is to evaluate Efficacy, Safety and Tolerability of AZD1656 as Add-on Treatment to Metformin in TD2M Patients

Type II Diabetes Mellitus

AstraZeneca530 participantsStarted Oct 2009

Temuco, Araucania, Chile • Brentwood, TN, Chile • Santiago, Chile +74 more locations

PreviousPage 1035 of 1134Next

in New York

Heart Diseasein New York